Realta Investment Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Realta Investment Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-33	Closed	-$1.36K	–	509
2024 Q2	$1.36K	Hold	33	–	–	﹤0.01%	767
2024 Q1	$1.48K	Buy	+33	New	+$1.5K	﹤0.01%	786
2023 Q4	–	Sell	-33	Closed	-$1.58K	–	558
2023 Q3	$1.58K	Hold	33	–	–	﹤0.01%	766
2023 Q2	$1.58K	Buy	+33	New	+$1.65K	﹤0.01%	816
2023 Q1	–	Sell	-33	Closed	-$1.64K	–	567
2022 Q4	$1.64K	Hold	33	–	–	﹤0.01%	828
2022 Q3	$2K	Buy	+33	New	+$1.86K	﹤0.01%	793

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Realta Investment Advisors's GNOM Position: Q3 2024 in Review

Realta Investment Advisors sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2024, closing a stake of 33 shares — an estimated $1.36K sold.

Realta Investment Advisors first reported a position in GNOM in Q3 2022 and held it in 6 quarters. The position peaked at $2K in Q3 2022. 64 funds tracked by Wall St. Rank hold GNOM as of Q3 2024.

Realta Investment Advisors reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
Realta Investment Advisors sold 33 Global X Genomics & Biotechnology ETF shares in Q3 2024, an estimated $1.36K.
Realta Investment Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q3 2022 and held it in 6 quarters.
Realta Investment Advisors's Global X Genomics & Biotechnology ETF position peaked at $2K in Q3 2022.
64 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2024.

Based on Realta Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.